AP505

· AP Biosciences Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AP505, covering 2024-12-09 to 2024-12-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AP505 Injection in Patients With Advanced Malignant Solid Tumors [Phase 1]